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Summary  Peru  is  an  increasingly  popular  tourist  destination  that  poses  a risk  to
travelers  due  to  endemic  vector-borne  diseases  (VBDs).  The  objective  of  our  study
was  to  determine  which  factors  are  associated  with  receiving  pre-travel  advice
(PTA)  for  VBDs  among  travelers  visiting  Cuzco,  Peru.  A  cross-sectional  secondary
analysis  based  on  data  from  a  survey  among  travelers  departing  Cuzco  at  Alejandro
Velazco  Astete  International  Airport  during  the  period  January—March  2012  was  con-
ducted.  From  the  1819  travelers  included  in  the  original  study,  1717  were  included
in  secondary  data  analysis.  Of  these  participants,  42.2%  received  PTA  and  2.9%  were
informed  about  vector-borne  diseases,  including  yellow  fever  (1.8%),  malaria  (1.6%)
and  dengue  fever  (0.1%).  Receiving  information  on  VBDs  was  associated  with  visiting
areas  endemic  to  yellow  fever  and  dengue  fever  in  Peru.  The  only  disease  travel-
ers  received  speciﬁc  recommendations  for  before  visiting  an  endemic  area  for  was
yellow  fever.  Only  1  in  30  tourists  received  information  on  VBD  prevention;  few  of
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re-travel  advice  (PTA)  and  vaccinations  aim  to
educe risks  associated  with  travel  [1—3]. This  is
specially  important  when  tourists  travel  to  pop-
lar destinations  in  tropical  and  subtropical  areas
ith vector-borne  diseases  (VBDs)  endemic  to  the
ocation  of  interest  [4].  Promotion  of  tropical  des-
inations  is  increasing  the  number  of  trips  to  areas
here dengue  fever,  yellow  fever,  malaria  and
ther vector-borne  diseases  are  endemic.  Emerging
ot spots  of  tourism  in  these  areas  pose  simi-
ar risks  to  travelers,  although  each  location  may
ave unique  characteristics.  Peru  has  registered  a
teady growth  in  foreign  arrivals  for  more  than  a
ecade with  [5,6]  rates  of  international  tourists
eaching approximately  three  and  a  half  million  per
ear [7,8].  In  Peru,  travelers  may  be  exposed  to
 variety  of  coastal,  highland,  and  jungle  environ-
ents  in  just  a  few  hours.  The  varied  conditions
nd risks  associated  with  these  environments  make
estination-speciﬁc  health  advice  important.  Both
nternational  travelers  that  come  to  Peru  and
omestic tourists  may  be  exposed  to  VBDs,  which
an cause  major  morbidity  and  mortality  [9].  This
isk exists  in  countries  such  as  Peru  where  the  devel-
pment  of  travel  medicine  and  PTA  is  incipient  and
here the  few  physicians  that  are  trained  in  travel
edicine  and  able  to  provide  information  about
ravel  risks  are  concentrated  in  different  major
etropolitan regions,  such  Lima,  Cusco,  Iquitos  and
uaraz.
Most travel  medicine  studies  in  Peru  have  not
ddressed VBDs  [10—13]. Data  on  the  prevention
f conditions  such  as  dengue  fever,  malaria,  and
ellow  fever  among  travelers  in  Peru  are  missing,
espite their  importance  in  understanding  patterns
f morbidity  among  this  population.  The  objective
f the  present  study  is  to  evaluate  the  factors  that
re associated  with  PTA  for  the  prevention  of  VBDs
mong tourists  visiting  Cuzco.
aterials and methodstudy design
 cross-sectional  study  was  conducted  using  infor-
ation  initially  collected  for  a  primary  study.  This
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emic  area  were  warned  about  speciﬁc  risks  for  infectious
ese  important  ﬁndings  show  that  most  tourists  who  travel
r  the  prevention  of  infectious  and  VBD,  which  can  affect
eir  countries  of  origin  as  well.
ziz  University  for  Health  Sciences.  Published  by  Elsevier
nitial  study  was  conducted  as  part  of  a thesis  that
as been  approved  but  not  yet  published  and  com-
ares the  characteristics  of  foreign  tourists  and
eruvians  living  abroad  visiting  family  and  relatives
n Cuzco.
Cuzco  is  a city  in  southern  Peru  located  at  3400  m
bove sea  level  and  has  been  the  most  important
eruvian destination  for  travelers  around  the  world
ince 2007  when  Machu  Picchu,  an  Inca  sanctuary,
as selected  as  one  of  the  new  Seven  Wonders  of
he World  [14].
ollection and selection of the data
ata  were  collected  through  self-administered
urveys  in  the  departure  lounge  of  Cuzco’s  inter-
ational airport  between  January  and  March  2012.
fter the  ﬁnalization  of  the  primary  study,  the
ata collected  were  re-analyzed,  focusing  on  VBDs,
uring the  period  of  January—March  2013  by a
roup of medicine  students  under  the  guidance  of
he primary  study  author.  Subjects  older  than  18
ears were  selected  using  convenience  sampling
nd invited  to  participate  voluntarily  in  the  study.
ravelers  staying  in  Peru  longer  than  2  weeks  were
xcluded  from  the  study.
urveys
he  questionnaire  was  designed  as  a self-
dministered survey  with  open  and  closed-ended
uestions in  both  English  and  Spanish.  The  survey
sked about  basic  demographic  information,  coun-
ry of  residence,  travels  in  the  last  six  months,
re-travel advice  and  recommendations  given,  and
ood-hygienic  risk  behaviors  during  their  stay.
Prior to  survey  administration,  questions  were
valuated  for  quality  by  two  experts  on  the  topic
nd by  a  biostatistician,  and  later  by  a  group
f students  and  teachers,  all  from  the  unit  of
nstrumental validation  from  the  Master  of  Epi-
emiological  Research  Program  of  the  Universidad
eruana Cayetano  Heredia  (UPCH),  Lima,  Peru.
he principal  investigator  surveyed  a  group  of
0 tourists  who  evaluated  the  comprehensibility
f each  question  using  a numerical  scale  from  0
o 10  (0  =  I can’t  understand  the  question,  10  =  I
C.R.  Mejia  et  al.
Table  1  Characteristics  of  travelers  surveyed  in
Cuzco,  Peru.
Variables  n  (%)
Gender
Female  932  51.7
Male  871  48.3
Age  (years)a 32.9  (18—87.8)
Sought  travel  advice
before  departure
707 42.2
Topic  of  the  advice  received
Transmissible
diseases
199 10.9
Infectious  diseases  60  3.3
Vector-borne
diseases
53  2.9
Malaria  29  1.6
Dengue  1  0.1
Yellow  fever  33  1.8
Received  regionally  speciﬁc  information  about  vector
borne  diseases  during  consultation
Yellow  fever 6  10.5
Malaria  5  2.8
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understand  perfectly  the  question).  Questions  that
were evaluated  and  those  that  had  a  mean  of
less than  7 were  re-phrased  several  times  until  a
mean response  of  8  or  more  than  8  points  of  com-
prehensibility was  obtained.  Those  questions  were
ultimately  selected  for  the  ﬁnal  version  of  the  ques-
tionnaire.
Surveys  were  administered  by  trained  medical
students. On  the  ﬁrst  page  of  the  survey  there  was
a presentation  inviting  the  tourists  to  participate
in the  primary  study  and  also  information  regarding
the secondary  study  about  the  VBDs  and  PTA.
Variables deﬁnition
Pre-travel  advice  was  deﬁned  as  disease  prevention
recommendations  provided  by  a  healthcare  profes-
sional to  travelers  before  and  during  their  stay  in
Peru. Subjects  were  asked  to  list  all  the  prevention
recommendations  that  they  remembered  receiv-
ing. The  variables  selected  for  this  study  included:
gender; age;  purpose  of  travel;  seeking  pre-travel
advice; type  of  information  received;  and  whether
or not  the  participant  received  information  about
malaria,  dengue,  and  yellow  fever  prevention  in
Peru.
Statistical analysis
The  questionnaires  were  transcribed  into  Microsoft
Excel 2010  (Redmond,  WA).  The  statistical  analysis
was performed  using  STATA  software  version  11.1
for Windows  (Stata  Corp  LP,  College  Station,  TX).
Frequencies  and  percentages  were  used  to  describe
qualitative variables.  The  normality  of  quantitative
variables was  analyzed  by  the  Shapiro—Wilk  test.
Means  or  medians  were  used  accordingly.  Bivari-
ate regression  analysis  was  performed  and  crude
prevalence  ratios  (PR)  and  95%  conﬁdence  intervals
(95%CI)  were  calculated.  We  used  a  level  of  p <  0.05
to indicate  statistical  signiﬁcance.
Ethical guidelines
The  Institutional  Ethics  Committee  of  Cayetano
Heredia Peruvian  University  approved  the  protocol.
Subjects verbally  provided  their  consent  to  partic-
ipate.
ResultsOverall,  1819  international  travelers  were  sur-
veyed. Ninety-four  travelers  with  residency  in
Peru and  8 tourists  under  the  age  of  18  years
a
o
v
(Dengue  fever 0  0.0
a Median and age range.
ld  were  excluded.  After  excluding  these  partici-
ants,  a total  of  1717  participants  were  included
n the  study,  51.7%  (938)  of  whom  were  female
ith an  overall  median  age  of  32.9  years  (range:
8—87.7 years).  Only  42.2%  (707)  of  the  travel-
rs sought  PTA  and  2.9%  (53)  received  medical
dvice on  VBD  prevention.  Among  tourists  who  vis-
ted or  planned  to  visit  an  area  endemic  to  VBD
n Peru,  10.5%  (6/57)  received  advice  on  yellow
ever, 2.8%  (5/179)  received  advice  on  malaria,
nd none  (0/154)  received  advice  on  dengue  fever
Table  1).  Within  the  106  recommendations  on
revention  of  infectious  diseases,  65%  (69)  of
articipants  received  advice  about  vaccines  for  spe-
iﬁc diseases  and  while  8%  (9)  received  advice
egarding taking  pills  prophylactically.  Other  impor-
ant recommendations  participants  received  were
oncerning  prevention  of  traveler’s  diarrhea  (40):
6 of  which  were  concerned  prevention,  5 con-
erned taking  pills  and  3  concerned  vaccination  for
his condition  (Table  1).
A description  of  demographic  variables  of  PTA
s included  in  Table  2. Having  PTA  on  VBDs  was
ssociated with  visiting  Peruvian  endemic  areas  in
ellow fever  (OR  =  4.4,  95%CI  1.8—10.5)  and  dengue
ever (OR  =  2.6,  95%CI  1.3—5.2).  No  associations
ere found  between  having  PTA  and  sex  (p = 0.56),
ge (p  = 0.15),  purpose  of  travel  (p  =  0.93),  number
f days  in  Peru  before  visiting  Cuzco  (p  =  0.88),  or
isiting an  area  where  is  malaria  endemic  (p  =  0.90)
Table  2).
Pre-travel  advice  concerning  vector-borne  diseases  461
Table  2  Characteristics  associated  with  receiving  medical  information  regarding  vector-borne  diseases  during  PTA
among  travelers  to  Cuzco.
Was  informed  about  vector-borne
diseases  during  PTA?
PR (95%CI)
Yes  No
N  %  N  %
Age  (years)a 37.7 16.0 38.7 15.8  0.99  (0.98—1.01)
Sex
Male  19  35.9 852 48.7 0.59 (0.33—1.04)
Female  34  64.1  898  51.3
Reason  to  travel
Tourism  38  73.1  1246  71.0  1.11  (0.59—2.06)
Other  14  26.9  508  29.0
Days  in  Peru  before  arriving  to  Cuzcoa 3.8  ±4.2  5.1  ±12.3 0.99  (0.95—1.02)
Traveled  to  a  malaria  risk  area
Yes  6  11.3  173  9.8  1.18  (0.50—2.79)
No  47  88.7  1593  90.2
Traveled  to  a  dengue  risk  area
Yes  12  22.6  142  8.0  3.35  (1.72—6.51)
No  41  77.4  1624  92.00
Traveled  to  a  yellow  fever  risk  area
Yes  7  13.2  50  2.8  5.22  (2.27—12.14)
No  46  86.8  1716  97.2
PTA: pre-travel advice; PR: crude prevalence ratio obtained with logistic regression; 95%CI: conﬁdence interval at 95%.
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Visiting  an  area  where  yellow  fever  is  endemic
as strongly  associated  with  receiving  preventive
dvice for  that  disease  (OR  =  6.3,  95%CI  2.4—16.4).
o association  was  found  between  visiting  areas
here malaria  is  endemic  (p  =  0.23)  and  dengue
ever is  endemic  (p  =  0.99)  and  receiving  advice  for
hose illnesses  (Table  3).
iscussion
his  study  evaluated  factors  associated  with  receiv-
ng PTA  about  VBDs  among  visitors  to  Cuzco.  This  is
n important  topic  because  in  Peru,  travel  medicine
s beginning  to  develop  and  currently  is  only  focused
n treating  returning  travelers  for  disease,  not  pre-
ention.  This  topic  is  also  highly  relevant  because
f the  large  increase  in  international  and  national
ourism in  the  country  [5,6]. Medical  practitioners
iving PTA  to  travelers  who  are  visiting  Peru  need
o be  aware  of  this  reality  and  ask  for  the  itinerary
f their  patients  in  order  to  assess  if  they  are  at
isk of  traveling  to  a  zone  with  endemic  infectious
iseases, particularly  VBDs,  and  provide  prevention
ecommendations  accordingly.
Our study  found  that  just  a  proportion  of  tourists
42.2%) had  received  PTA  prior  their  trip.  Ideally,
ll travelers  should  receive  PTA  prior  to  traveling
a
b
a
Cnternationally.  Studies  around  the  world  have
ound similar  results  on  the  proportion  of travelers
ho received  PTA:  36%  of  travelers  at  an  interna-
ional airport  in  New  York  [15],  30%  of immigrants
rom Amsterdam  [16]  and  52%  of  passengers  trav-
ling at  international  airports  in  London,  Paris  and
unich [17]. The  varying  frequency  of  PTA  depend-
ng on  the  location  can  be  explained  by ﬁndings
rom other  studies.  For  example,  ﬁnancial  consid-
rations,  language  barriers,  health  beliefs,  lack  of
wareness and  fear  of  immigration  authorities  [18]
re  all  factors  that  other  studies  have  found  affect
he likelihood  of  receiving  PTA.  An  even  smaller
roportion of  tourists  who  visited  or  were  plan-
ing to  visit  areas  where  VBD  are  endemic  received
revention recommendations.  Therefore,  a signif-
cant number  of  tourists  that  are  visiting  Peru  are
xposed to  VBDs  without  receiving  advice  and  are
t the  risk  of  becoming  ill  and  introducing  these
iseases into  their  own  countries  if  epidemiological
onditions are  suitable  [1,18].
Our  study  found  that  4  of  10  tourists  sought
dvice from  a  healthcare  practitioner  when  prepar-
ng for  their  trip.  Similarly,  studies  conducted
t other  tourist  destinations  have  reported  that
etween  30  and  50%  of  travelers  seek  pre-travel
dvice [18—21].  In  contrast,  a previous  study  in
uzco showed  that  93.6%  of  travelers  sought  PTA
462  C.R.  Mejia  et  al.
Table  3  Analysis  of  speciﬁc  disease  information  received  during  PTA  according  to  travel  to  endemic  vector-borne
disease  area  in  Peru.
Traveled  to  an  area  in  Peru  with:  Vector-borne  disease  information
received  during  PTA
OR (95%CI)
Yes  No
N  %  N  %
Malaria
Yes 5 2.8 174  97.2 1.93 (0.72—5.14)
No  24  1.5  1616  98.5
Dengue  fever
Yes  0  0  154  100.0  —
No  1  0.1  1664  99.9
Yellow  fever
Yes  6  10.5  51  89.5  7.56  (3.00—19.11)
No  27  1.5  1735  98.5
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before  departure  and  60%  of  them  received  this
advice  from  a  healthcare  professional  [16].  This
difference  may  be  explained  by  differences  in  the
proﬁles  of  the  travelers  that  arrive  in  Cuzco,  the
risk proﬁle  of  the  itineraries  of  those  included  in
the study,  and  the  study  designs.
The number  of  travelers  that  are  at  risk  of
becoming infected  with  a  VBD  and  who  received
speciﬁc information  about  their  destination  was  low
(10.5% for  yellow  fever,  2.8%  for  malaria,  and  0%
for dengue  fever).  Travelers’  risk  perceptions  and
willingness  to  seek  professional  health  professional
advice may  have  caused  these  low  rates  in  our  study
population.  In  addition,  barriers  to  travel  consul-
tation,  advice  recollection,  and  compliance  with
advice  were  have  been  described  in  other  studies
[20,21].  Travelers  with  little  or  no  knowledge  about
their exposure  risk  are  more  vulnerable  to  becom-
ing infected  with  vector-borne  diseases  endemic  to
Peru.
Yellow fever  prevention  information  was  more
often provided  to  travelers  visiting  yellow  fever
risk areas  compared  to  the  advice  for  other  VBDs.
The severity  of  yellow  fever  and  the  availability
of a  highly  effective  vaccine  may  have  inﬂuenced
healthcare professionals’  decisions  regarding  pro-
viding this  advice.  Although  yellow  fever  has  a
high case  fatality  rate,  malaria  and  dengue  fever
are far  more  common  and  cause  more  deaths
among travelers  [22].  Few  travelers  were  coun-
seled about  dengue  fever  prevention,  implying
that limited  information  regarding  mosquito  bites
was received  as  well.  The  same  precautions  for
dengue  fever  and  mosquito  bites  may  aid  in  the
prevention  of  other  VBD  in  overlapping  endemic
areas in  Peru.  This  is  especially  important  in  Peru,
p
w
y
ggistic regression; 95%CI: conﬁdence interval at 95%.
here  the  vast  majority  of travelers  does  not
ontact a  travel  agency  before  arriving  and  rely
n local  services  [23]. Additionally,  internation-
lly, travel  agencies  usually  perceive  PTA  to  be
mportant  and  recommend  clients  seek  guidance
rom healthcare  professions  according  to  interna-
ional  recommendations  and  international  health
egulations.
This study  was  a  secondary  data  analysis  and,
s a  result,  has  different  study  limitations.  First,
 number  of  factors  that  that  may  inﬂuence  rates
nd the  type  of  VBD  advice  sought  by  travelers  were
ot evaluated,  such  as:  having  a  disease  in a  pre-
ious travel;  having  a relative,  friend,  or  doctor
uggest having  a  physical  prior  to  travel;  or  media
nﬂuence  on  seeking  PTA,  for  example  [23].  Addi-
ionally,  a  convenience  sample  was  used,  which
imits the  generalization  of  these  results  to  other
roups.  Finally,  a limited  number  of  subjects  at  risk
or VBDs  were  included,  limiting  the  power  of  the
nalysis.
onclusion
n  conclusion,  a  small  proportion  of  travelers  who
ere at risk  for  VBDs  in  Peru  received  PTA.  This
s concerning  given  that  beyond  individual  risk  for
he disease,  a  tourist  infected  with  a  VBD  also
isks spreading  the  infectious  disease  to  their  coun-
ry of  origin.  When  PTA  was  received,  advice  was
rimarily  focused  on  yellow  fever  prevention;  this
as also  strongly  associated  with  traveling  to  a
ellow fever  risk  area.  Analyzing  the  sociodemo-
raphic characteristics  of  travelers  that  received
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[18] Bauer I. Australian senior adventure travellers to Peru: max-
imising older tourists’ travel health experience. Travel Medre-travel  advice  concerning  vector-borne  diseases
TA  can  be  useful  for  identifying  new  charac-
eristics among  those  who  have  PTA  and  using
hese ﬁndings  to  design  other  studies.  Addition-
lly, these  ﬁndings  can  encourage  health  and  travel
nstitutions  in  many  countries  to  implement  appro-
riate strategies  aimed  at  groups  characterized
rom the  ﬁndings  of  this  study  and  others  in
he future.  Additional  efforts  focused  on  the  pre-
ention  of  malaria  and  dengue  are  needed,  as
ell as  for  other  emerging  VBDs  such  as  Chikun-
unya and  Zika  which  have  now  appeared  in  Latin
merica  [24,25]. Future  improvements  to  VBD
ill also  generate  political  motivation  for  sup-
orting the  development  of  travel  medicine  in
eru.
uthors’ contributions
hristian  R.  Mejia  was  responsible  for  the  concep-
ion and  design  of  the  work,  in  addition  to  the
ontribution to  the  study  data,  and  providing  statis-
ical, technical  and  administrative  advice.  Christian
. Mejia  also  critically  revised  the  manuscript  along
ith Alfonso  J.  Rodriguez-Morales.  Both,  together
ith Aleksandar  Cvetkovic-Vega,  Emperatriz  Cen-
eno, Briggitte  Cruz  and  Edison  Delgado  Valencia
pproved the  ﬁnal  manuscript.  Collection  and  deliv-
ry of  results  was  by  Edison  Delgado,  who  along  with
mperatriz  Centeno,  Briggitte  Cruz  and  Aleksandar
vetkovic drafted  the  manuscript.
unding
his  investigation  was  self-funded  by  the  authors.
ompeting interests
one  declared.
thical approval
ot  required.
cknowledgements
e  thank  Lisbeth  Hinojosa  and  Luis  Castillo,  from
niversidad  Nacional  de  San  Antonio  Abad  del
uzco,  who  performed  the  data  entries.  We  also
hank  Dr.  Andres  G.  Lescano  and  Dr.  Miguel  M.
abada,  for  his  guidance  to  conduct  this  study.463
eferences
[1] Chiodini JH, Anderson E, Driver C, Field VK, Flaherty
GT, Grieve AM, et al. Recommendations for the practice
of travel medicine. Travel Med Infect Dis 2012;10(3):
109—28.
[2] Heywood AE, Watkins RE, Iamsirithaworn S, Nilvarangkul K,
MacIntyre CR. A cross-sectional study of pre-travel health-
seeking practices among travelers departing Sydney and
Bangkok airports. BMC Public Health 2012;12(1):321.
[3] Heywood AE, Zhang M, MacIntyre CR, Seale H. Travel
risk behaviours and uptake of pre-travel health preven-
tions by university students in Australia. BMC Infect Dis
2012;12(1):43.
[4] Patel D, Simons H. Yellow fever vaccination: is one dose
always enough? Travel Med Infect Dis 2013;11(5):266—73.
[5] Mincetur. Llegada de turistas internacionales (2004—2011);
2012. Available from: http://www.mincetur.gob.pe/
newweb/portals/0/turismo/PERU Lleg Tur por pais 2004
2011.pdf [Internet, cited 02.02.12].
[6] Mincetur. Llegada de visitantes Nacionales y Extranjeros a
Sitios Turísticos: Cusco; 2015. Available from: http://www.
mincetur.gob.pe/newweb/Default.aspx?tabid=3459 [Inter-
net, cited 05.11.15].
[7] Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J,
Gubler DJ, et al. Dengue: a continuing global threat. Nat
Rev Microbiol 2010;8(December (12)):S7—16.
[8] Bauer I. Relationships between female tourists and male
locals in Cuzco/Peru: implications for travel health educa-
tion. Travel Med Infect Dis 2009;7(6):350—8.
[9] McGraw EA, O’Neill SL. Beyond insecticides: new thinking
on an ancient problem. Nat Rev Microbiol 2013;11(February
(3)):181—93.
10] Salazar H, Swanson J, Mozo K, Clinton White A, Cabada MM.
Acute mountain sickness impact among travelers to Cusco,
Peru: acute mountain sickness in travelers to Cusco. J Travel
Med 2012;19(July (4)):220—5.
11] Cabada MM, Maldonado F, Mozo K, Dziuba N, Gotuzzo
E. Pre-travel preparation for Cusco, Peru: a comparison
between European and North American travelers. J Travel
Med 2010;17(November (6)):382—6.
12] Cabada MM, Maldonado F, Quispe W, Mozo K, Serrano E,
González E, et al. Risk factors associated with diarrhea
among international visitors to Cuzco, Peru. Am J Trop Med
Hyg 2006;75(November (5)):968—72.
13] Dammert AC, Galdo JC, Galdo V. Preventing dengue through
mobile phones: evidence from a ﬁeld experiment in Peru.
J Health Econ 2014;35(1):147—61.
14] Prom Peru. Presentacion Perﬁl del Turista Extran-
jero; 2014. Available from: http://www.siicex.gob.pe/
siicex/portal5ES.asp? page =596.00000 [Internet, cited
02.11.15].
15] Hamer DH, Connor BA. Travel health knowledge, attitudes
and practices among United States travelers. J Travel Med
2004;11(1):23—6.
16] Bacaner N, Stauffer B, Boulware DR, Walker PF, Keystone
JS. Travel medicine considerations for North Amer-
ican immigrants visiting friends and relatives. JAMA
2004;291(23):2856—64.
17] Herck K, Zuckerman J, Castelli F, Damme P, Walker E, Stef-
fen R. Travelers’ knowledge, attitudes, and practices on
prevention of infectious diseases: results from a pilot study.Infect Dis 2012;10(March (2)):59—68.
[[
[464  
[19] Cabada MM, Maldonado F, Quispe W,  Serrano E, Mozo
K, Gonzales E, et al. Pretravel health advice among
international travelers visiting Cuzco, Peru. J Travel Med
2005;12(2):61—5.
[20] Tafuri S, Guerra R, Gallone MS, Cappelli MG, Lanotte S,
Quarto M, et al. Effectiveness of pre-travel consultation in
the prevention of travel-related diseases: a retrospective
cohort study. Travel Med Infect Dis 2014;12(6):745—9.
[21] Pavli A, Silvestros C, Patrinos S, Lymperi I, Maltezou HC.
Pre-travel preparation practices among business travellers
to tropical and subtropical destinations: results from the
Athens International Airport Survey. Travel Med Infect Dis
2014;12(4):364—9.
[22] Jensenius M, Han PV, Schlagenhauf P, Schwartz E, Parola
P, Castelli F, et al. Acute and potentially life-threatening
Available  online  at  www
ScienceDC.R.  Mejia  et  al.
tropical diseases in western travelers — a GeoSentinel
multicenter study, 1996—2011. Am J Trop Med Hyg
2013;88(February (2)):397—404.
23] Provost S, Soto JC. Predictors of pretravel consulta-
tion in tourists from Quebec (Canada). J Travel Med
2001;8(2):66—75.
24] Rodríguez-Morales AJ. Zika: the new arbovirus threat for
Latin America. J Infect Dev Ctries 2015;9(6):684—5.
25] Rodriguez-Morales AJ, Cárdenas-Giraldo EV, Montoya-Arias
CP, Guerrero-Matituy EA, Bedoya-Arias JE, Ramírez-
Jaramillo V, et al. Mapping chikungunya fever in munic-
ipalities of one coastal department of Colombia (Sucre)
using Geographic information system (GIS) during 2014 out-
break: implications for travel advice. Travel Med Infect Dis
2015;13(3):256—8.
.sciencedirect.com
irect
